Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Williams

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activityPatrick J Donohue, Christine M Richards, Sharron A N Brown, et al.
Plos One|September 27, 2014
Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1Lilia Maneva-Radicheva, Christina Amatya, Camille Parker, et al.
Plos One|August 8, 2014
Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitusTadeusz Kolodka, Matthew L Charles, Arvind Raghavan, et al.
Cancer Research|January 25, 2003
2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathwayTheresa M LaVallee, Xiaoguo H Zhan, Michelle S Johnson, et al.
Blood|January 24, 2004
Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activityTodd A Hembrough, Jose F Ruiz, Bonnie M Swerdlow, et al.
BMC Cancer|November 10, 2020
Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in cancerMark S Williams, Naseer J Basma, Fabio M R Amaral, et al.
American Journal of Hematology|April 13, 2020
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genesJuliana Schwaab, Nicole Naumann, Johannes Luebke, et al.
The Journal of Infectious Diseases|September 5, 2023
Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug DevelopmentRobert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activityPatrick J Donohue, Christine M Richards, Sharron A N Brown, et al.
Plos One|September 27, 2014
Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1Lilia Maneva-Radicheva, Christina Amatya, Camille Parker, et al.
Plos One|August 8, 2014
Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitusTadeusz Kolodka, Matthew L Charles, Arvind Raghavan, et al.
Cancer Research|January 25, 2003
2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathwayTheresa M LaVallee, Xiaoguo H Zhan, Michelle S Johnson, et al.
Blood|January 24, 2004
Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activityTodd A Hembrough, Jose F Ruiz, Bonnie M Swerdlow, et al.
BMC Cancer|November 10, 2020
Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in cancerMark S Williams, Naseer J Basma, Fabio M R Amaral, et al.
American Journal of Hematology|April 13, 2020
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genesJuliana Schwaab, Nicole Naumann, Johannes Luebke, et al.
The Journal of Infectious Diseases|September 5, 2023
Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug DevelopmentRobert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, et al.
Pageof 5